AMBRA1 and autism: Since autism is usually diagnosed in children before the age of 3 years, assessment of neurobehavioral developmental milestones and early ultrasound communication in neonatal mice up to the age of 3–4 weeks has been important for further characterization of the Ambra1+/− mouse model of autism.